Abstract

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease. Coronary vascular events caused by atherosclerosis are one of the leading causes of death in RA. The review gives the results of studies of the role of interleukin-6 (IL-6) in the development of autoimmune inflammation and cardiovascular diseases. The link between IL-6, inflammation, and blood lipid spectrum is considered. Attention is focused on the lipid-lowering and pleiotropic effects of statins. There is information of the effects of IL-6 receptor inhibitors (Tocilizumab – TCZ)) on blood lipid levels in RA. The implication of IL-6 in the pathogenesis of atherosclerosis in RA and the effects of TCZ on the development and progression of atherosclerosis need future investigations.

Highlights

  • Для ссылки: Удачкина ЕВ, Новикова ДС, Попкова ТВ, Насонов ЕЛ

  • Coronary vascular events caused by atherosclerosis are one of the leading causes of death in RA

  • The review gives the results of studies of the role of interleukin-6 (IL-6) in the development of autoimmune inflammation and cardiovascular diseases

Read more

Summary

Introduction

Для ссылки: Удачкина ЕВ, Новикова ДС, Попкова ТВ, Насонов ЕЛ. Роль интерлейкина 6 в развитии атеросклероза при ревматоидном артрите. Role of interleukin-6 in the development of atherosclerosis in rheumatoid arthritis E.V. Udachkina, D.S. Novikova, T.V. Popkova, E.L. Nasonov Key word: interleukin-6, atherosclerosis, lipid spectrum, statins, inflammation, rheumatoid arthritis, tocilizumab. При сравнении с группой ПЛ (n=20) установлено, что независимо от степени снижения уровня ХС ЛПНП симвастатин приводит к уменьшению концентрации СРБ и ИЛ6.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.